يعرض 1 - 10 نتائج من 53 نتيجة بحث عن '"Brinkkemper, Mitch"', وقت الاستعلام: 1.17s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.soton.ac.uk/490033/1/s41541-024-00862-8.pdfTest; Del Moral-Sánchez, Iván, Wee, Edmund G, Xian, Yuejiao, Lee, Wen-Hsin, Allen, Joel D., Torrents de la Peña, Alba, Fróes Rocha, Rebeca, Ferguson, James, León, André N., Koekkoek, Sylvie, Schermer, Edith E., Burger, Judith A., Kumar, Sanjeev, Zwolsman, Robby, Brinkkemper, Mitch, Aartse, Aafke, Eggink, Dirk, Han, Julianna, Yuan, Meng, Crispin, Max, Ozorowski, Gabriel, Ward, Andrew B., Wilson, Ian A., Hanke, Tomáš, Sliepen, Kwinten and Sanders, Rogier W. (2024) Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines. NPJ Vaccines, 9 (1), [74]. (doi:10.1038/s41541-024-00862-8 ).

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: University of Toyama, Bill and Melinda Gates Foundation, National Science Foundation, Vir Biotechnology, amfAR, The Foundation for AIDS Research, Howard Hughes Medical Institute, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Pfizer, National Institute of Allergy and Infectious Diseases, GlaxoSmithKline, University of Washington, Burroughs Wellcome Fund, Defense Threat Reduction Agency

    المصدر: Cell Reports Medicine ; volume 3, issue 10, page 100780 ; ISSN 2666-3791

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المصدر: Brouwer , P J M , Brinkkemper , M , Maisonnasse , P , Dereuddre-Bosquet , N , Grobben , M , Claireaux , M , de Gast , M , Marlin , R , Chesnais , V , Diry , S , Allen , J D , Watanabe , Y , Giezen , J M , Kerster , G , Turner , H L , van der Straten , K , van der Linden , C A , Aldon , Y , Naninck , T , Bontjer , I , Burger , J A , Poniman , M ....

    وصف الملف: application/pdf

  10. 10
    دورية أكاديمية

    المساهمون: Immunologie des maladies virales, auto-immunes, hématologiques et bactériennes (IMVA-HB), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Imperial College London, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, University of Texas Medical Branch at Galveston, Icahn School of Medicine at Mount Sinai New York (MSSM), Department of Medical Microbiology and Infection Prevention Amsterdam, University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA), Amsterdam UMC - Amsterdam University Medical Center, Life and Soft, The Scripps Research Institute La Jolla, San Diego, Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre National de Référence des virus respiratoires (dont la grippe et le SARS-CoV2) Paris (CNR - laboratoire associé), Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), This study was supported by the Netherlands Organization for Scientific Research (NWO) Vici grant (to R.W.S.), the Bill & Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (CAVD) grant INV-002022 (to R.W.S.), the Fondation Dormeur, Vaduz (to R.W.S. and to M.J.v.G.) and Health Holland PPS-allowance LSHM20040 (to M.J.v.G.). M.J.v.G. is a recipient of an AMC Fellowship, Amsterdam UMC and a COVID-19 grant of the Amsterdam Institute of Infection and Immunity, the Netherlands. R.W.S and M.J.v.G. are recipients of support from the University of Amsterdam Proof of Concept fund (contract no 200421) as managed by Innovation Exchange Amsterdam (IXA). The Infectious Disease Models and Innovative Therapies (IDMIT) research infrastructure is supported by the “Programme Investissements d’Avenir”, managed by the ANR under reference ANR-11-INBS-0008. The Fondation Bettencourt Schueller and the Region Ile-de-France contributed to the implementation of IDMIT’s facilities and imaging technologies. The NHP study received financial support from REACTing, the Fondation pour la Recherche Médicale (FRM, France, AM-CoV-Path) and the European Infrastructure TRANSVAC2 (730964). The virus stock used in NHPs was obtained through the EVAg platform (https://www.european-virus-archive.comTest/), funded by H2020 (653316). Work performed at Duke University was supported by the CoVPN grant (NIH AI46705) (to D.C.M.). The Ad5-hACE2 mouse work was supported in part by NIAID R21AI157606 (L.C.), and was partially supported by CRIP (Center for Research for Influenza Pathogenesis), an NIAID supported Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C) (A.G.S.), by supplements to NIAID grant U19AI135972 and DoD grant W81XWH-20-1-0270, by the Defense Advanced Research Projects Agency (HR0011-19-2-0020), and by the generous support of the JPB Foundation, the Open Philanthropy Project (research grant 2020-215611 (5384) and anonymous donors to A.G.S. Part of this study was supported by the Bill and Melinda Gates Foundation through grants OPP1170236 and INV-004923 (I.A.W.) and through the Global Health Vaccine Accelerator Platforms (GH-VAP) and the Coronavirus Immunotherapy Consortium (CoVIC) (Nexelis)., ANR-11-INBS-0008,IDMIT,Infrastructure nationale pour la modélisation des maladies infectieuses humaines(2011), ANR-20-COVI-0021,AM-Cov-Path,Pathogénèse de l'infection SARS-Cov-2 dans un modèle de primates non humains : un modèle pour les traitements et la prévention(2020), European Project: 730964, H2020, RIA,H2020-INFRAIA-2016-1,TRANSVAC2(2017), European Project: 653316,H2020,H2020-INFRAIA-2014-2015,EVAg(2015)

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34671037; info:eu-repo/grantAgreement//730964/EU/European Vaccine Research and Development Infrastructure/TRANSVAC2; info:eu-repo/grantAgreement//653316/EU/European Virus Archive goes global/EVAg; pasteur-04098221; https://pasteur.hal.science/pasteur-04098221Test; https://pasteur.hal.science/pasteur-04098221/documentTest; https://pasteur.hal.science/pasteur-04098221/file/s41467-021-26354-0.pdfTest; PUBMED: 34671037; PUBMEDCENTRAL: PMC8528857